Gujrathi Sheila insider trades
Gujrathi Sheila has filed 18 Form 4s with the SEC that we hold, for VTYX (Director), Janux Therapeutics, Inc. (JANX) (Director) and Processa Pharmaceuticals, Inc. (PCSA) (Director). Across all of them we count 1 purchase worth $300.3K and 1 sale worth $3.4M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 100,000 shares of VTYX worth $3.4M, dated 2023-03-30. The first filing on our record is dated 2021-10-25 and the latest 2026-07-30.
VTYX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-03-30 | S, sale reported on Form 4 | 100,000 | $3.4M | 2023-03-31 |
| 2024-12-23 | P, purchase reported on Form 4 | 130,000 | $300.3K | 2024-12-26 |
Janux Therapeutics, Inc. (JANX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Processa Pharmaceuticals, Inc. (PCSA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1575202) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms